Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals

Conclusion In this interferon-free era, PegIFN-based regimens remain a safe and effective option for selected HCV patients.
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research